pneumoniae; however, there have been reports from other enterobacterial genera, including Enterobacter, Salmonella and Shigella.
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The mcr-1 and mcr-2 genes have both been identified from cattle and pigs. [1] [2] [3] In addition, the mcr-1 gene has been identified from chickens, 4 but also from river samples and vegetables. 5 MCR-1 and MCR-2, sharing 81% amino acid identity, are phosphoethanolamine transferases of 541 and 538 amino acids, respectively. 2, 3 They add phosphoethanolamine to the lipid A moiety of LPS, leading to a more cationic LPS structure and consequently to resistance to polymyxins. 1 We recently showed that some Moraxella species might constitute putative reservoirs of MCR-like proteins, with corresponding genes located on the chromosome of these species. 6 Hence, MCRlike proteins were identified in Moraxella catarrhalis, Moraxella lincolnii, Moraxella porci and Moraxella osloensis. They all share significant amino acid identities with MCR-1 and MCR-2, ranging from 59% to 64%. 6 Even though these Moraxella species have been shown to carry intrinsic mcr-like genes, these genes remain quite distantly related to the plasmid-borne mcr-1 and mcr-2.
We recently had the opportunity to investigate another Moraxella species. Moraxella pluranimalium strain 248-01 T has been isolated from the nasal turbinate of a healthy pig in Spain. 7 M. pluranimalium is an aerobic and catalase-and oxidase-positive Gram-negative coccus that grows at temperatures of 22-37 C. 7 PCR assays with internal primers specific for both mcr-1 and mcr-2, as published, 1 allowed us to obtain an amplicon that was further sequenced. Internal outward primers were then designed and used for an inverse PCR strategy, as previously performed. 6 The sequence of the entire mcr gene was thus obtained and it revealed that this new enzyme (termed MCR-2.2) was almost identical to MCR-2 (99% amino acid identity), with only 8 amino acid differences out of the 538 constituting the MCR-2 enzyme, and shared 82% amino acid identity with MCR-1.
Interestingly, the mcr-2.2 gene exhibits a G ! C content of 49.1%, which is in accordance with the total G ! C content of the genomes of different Moraxella species (45%), which agrees with the intrinsic origin of this gene in M. pluranimalium.
The corresponding gene, named mcr-2.2, was cloned into plasmid pBADb, the recombinant plasmid being then expressed in E. coli TOP10 by adding L-arabinose 1% (necessary for the expression of the cloned genes in this inducible vector), as performed for other mcr-like genes. 6 Then MICs of colistin were determined for the recombinant strains expressing mcr-1, mcr-2 and mcr-2.2 by broth microdilution (BMD), 1 and this showed that MCR-2.2 conferred exactly the same level of resistance as MCR-1 and MCR-2 (MIC 4 mg/L compared with 0.03 mg/L for the E. coli WT recipient strain), thus showing that the few differences in terms of amino acid sequence did not have an impact on resistance to colistin in E. coli.
Interestingly, the MIC of colistin determined by BMD for M. pluranimalium strain 248-01 was high (16 mg/L). Susceptibility to other antibiotics, determined by disc diffusion, showed that this strain had a penicillinase phenotype, with resistance to amoxicillin and ticarcillin removed by clavulanic acid. In addition, it was resistant to tetracycline, nalidixic acid and ciprofloxacin, but remained susceptible to all aminoglycosides, sulphonamides, chloramphenicol and fosfomycin.
Since the mcr-1 and mcr-2 genes are often identified on IncX4-type plasmid scaffolds, strain 248-01 was tested for the corresponding replicase gene as reported, 8 but it remained negative. No plasmid could be identified despite several extraction attempts and attempts to transfer a polymyxin resistance determinant by electro-transformation into an E. coli recipient strain also failed. 8 These negative results further suggest a chromosomal location of the mcr-2.2 gene. Since the mcr-1 gene is most often associated with the ISApl1 element, which has been shown to be involved in its acquisition, 9 and since IS1595 was found to be closely associated with mcr-2 (even though its involvement in the acquisition of the resistance gene has not yet been proven), 3 PCR specific for those IS elements was performed using DNA from strain 248-01 T as a template. Interestingly, positive signals were obtained for both ISs and sequencing confirmed a perfect identity with ISApl1 and a variant of IS1595 (97% nucleotide identity), respectively. However, PCR mapping showed that these ISs were not located upstream of the mcr-2.2 gene, in contrast to what is observed with both mcr-1 and mcr-2 genes when identified in enterobacterial isolates. This is another confirmation that ISApl1 may be found in Moraxella spp. after its identification in the genome of M. porci. Notably, the concomitant identification of IS1595 and of an mcr-2-like gene in the same M. pluranimalium strain further suggests that the mobilization event that led to the further dissemination of mcr-2 in Enterobacteriaceae had first occurred from M. pluranimalium.
This report most likely identifies the direct progenitor of the mcr-2 gene as M. pluranimalium, about which little is known so far. Strains belonging to this species have been recovered from pigs that were either healthy or suffering from pleuritis and polyserositis (nose, pleura and peritoneal cavity fluids), and from the brain of a sheep presenting with meningitis. It is likely that pigs might constitute a significant reservoir of M. pluranimalium. We speculate that the occurrence, selection, mobilization and dissemination of mcr-like genes might have occurred first in pigs. Since colistin is widely prescribed in veterinary medicine, in particular in pig farms, it represents a driving force for selection and spread of naturally occurring mcr-like resistance genes from Moraxella to Enterobacteriaceae. The present report paves the way for rethinking antibiotic policy in veterinary medicine, since this is likely a significant driving force for selection of antibiotic resistance traits that may have significant impacts in human medicine, as previously hypothesized. 10 
